Validation of a reference ELISA for estrone glucuronide using urine samples normalized by dilution to a constant rate of urine production

A direct enzyme linked immunosorbent assay (ELISA) system has been optimized as a reference method for the measurement of first statistically significant rises in estrone glucuronide excretion rates in human urine by analysing samples pre-diluted at the time of the collection by the women subjects to a constant urine production rate of 150 mL/h. Validation was achieved by correlation of the individual menstrual cycle profiles with the corresponding estrone glucuronide excretion rates determined by radioimmunoassay (RIA) on the same urine samples for a total of 221 samples from nine cycles. The pre-dilution procedure removed random variations due to fluctuations in the daily rate of urine excretion and minimized between sample matrix effects. When the ELISA data were correlated with the RIA data, Deming regression gave a slope of 1.20+/-0.03 and an intercept of 4.6+/-1.8 nmol/24h (r=0.944) and a random experimental error of 14.2 nmol/24h. The major difference in the measurements was a proportional error of 20%, which was present in either the ELISA or RIA methods or in both. Comparison of the standard normal variate transformation of the ELISA and RIA data gave hormonal profiles of the individual menstrual cycles (N=9) that overlapped almost perfectly. Statistically significant rises or falls in the magnitude of the excretion rate in one profile were mirrored faithfully in the other.

[1]  L. Bachas,et al.  Defined analyte-enzyme conjugates as signal generators in immunoassays. , 1993, Analytical biochemistry.

[2]  D. Talbot,et al.  Comparison between creatinine and pregnanediol adjustments in the retrospective analysis of urinary hormone profiles during the human menstrual cycle , 2004, Clinical chemistry and laboratory medicine.

[3]  J. Brown,et al.  Monitoring Induction of Ovulation by Rapid Radioimmunoassays of Oestrogen and Pregnanediol Glucuronides , 1981, Annals of clinical biochemistry.

[4]  Difference versus Mean Plots , 1997, Annals of clinical biochemistry.

[5]  M Annette Johansson,et al.  Matrix effects in immunobiosensor determination of clenbuterol in urine and serum. , 2004, The Analyst.

[6]  D D Baird,et al.  The timing of the “fertile window” in the menstrual cycle: day specific estimates from a prospective study , 2000, BMJ : British Medical Journal.

[7]  R. Fehring,et al.  A comparison of the fertile phase as determined by the Clearplan Easy Fertility Monitor and self-assessment of cervical mucus. , 2004, Contraception.

[8]  N Thomas,et al.  Prediction of ovarian cycle outcome by follicular characteristics, stage 1. , 1995, Human reproduction.

[9]  M. Batty.  Monitoring an Exponential Smoothing Forecasting System , 1969 .

[10]  B. Lasley,et al.  A prototype for ovulation detection: pros and cons. , 1991, American Journal of Obstetrics and Gynecology.

[11]  D. Baird,et al.  PULSATILE SECRETION OF LH, FSH, PROLACTIN, OESTRADIOL AND PROGESTERONE DURING THE HUMAN MENSTRUAL CYCLE , 1982, Clinical endocrinology.

[12]  R. Fleming,et al.  Correlation of ultrasonic and endocrinologic assessment of human follicular development. , 1979, American journal of obstetrics and gynecology.

[13]  M. Camberis,et al.  Evaluation of antibody- and antigen-coated enzymeimmunoassays for measuring oestrone-3-glucuronide concentrations in urine. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[14]  L. Blackwell,et al.  New assays for identifying the fertile period. , 1989, Supplement to International journal of gynecology and obstetrics.

[15]  E Godehardt,et al.  Estimated maximum failure rates of cycle monitors using daily conception probabilities in the menstrual cycle. , 2003, Human reproduction.

[16]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[17]  L. Guttman,et al.  Statistical Adjustment of Data , 1944 .

[18]  V. Thongboonkerd,et al.  Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: quantity, quality, and variability. , 2006, Journal of proteome research.

[19]  J. Brown,et al.  Current status of estrogen assay in gynecology and obstetrics. I. Estrogen assays in gynecology and early pregnancy. , 1972, Obstetrical & gynecological survey.

[20]  James B. Brown,et al.  Definition of the potentially fertile period from urinary steroid excretion rates. Part II. A threshold value for pregnanediol glucuronide as a marker for the end of the potentially fertile period in the human menstrual cycle , 1998, Steroids.

[21]  E. Diczfalusy,et al.  The prediction and/or detection of ovulation by means of urinary steroid assays. , 1986, Contraception.

[22]  John Brown,et al.  A RAPID METHOD FOR ESTIMATING OESTROGENS IN URINE USING A SEMI-AUTOMATIC EXTRACTOR , 1968 .

[23]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[24]  R. Hoover,et al.  Reproducibility and validity of radioimmunoassays for urinary hormones and metabolites in pre- and postmenopausal women. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[25]  S. Paek,et al.  Modeling of immunosensors under nonequilibrium conditions. I. Mathematic modeling of performance characteristics. , 1991, Analytical biochemistry.

[26]  Anand S Dighe,et al.  Improved detection of serum estradiol after sample extraction procedure. , 2004, Clinical chemistry.

[27]  J. Nisbet,et al.  Discrepancies in plasma estradiol values obtained with commercial kits. , 1987, Clinical chemistry.

[28]  K. Linnet,et al.  Performance of Deming regression analysis in case of misspecified analytical error ratio in method comparison studies. , 1998, Clinical chemistry.

[29]  D. Altman,et al.  Measuring agreement in method comparison studies , 1999, Statistical methods in medical research.

[30]  S. Cekan.  Biases in the assays of steroids and their binding proteins. , 1987, Journal of steroid biochemistry.

[31]  A. Pinol,et al.  Menstrual cycle hormonal profiles of women with and without premenstrual syndrome. , 1993, Journal of psychosomatic obstetrics and gynaecology.

[32]  James O Westgard,et al.  Use and interpretation of common statistical tests in method comparison studies. , 2008, Clinical chemistry.

[33]  James B. Brown,et al.  Application of time-series analysis for the recognition of increases in urinary estrogens as markers for the beginning of the potentially fertile period , 1992, Steroids.

[34]  C. Weinberg,et al.  Using the ratio of urinary oestrogen and progesterone metabolites to estimate day of ovulation. , 1991, Statistics in medicine.

[35]  J. Brown,et al.  Oestrogen and pregnanediol excretion through childhood, menarche and first ovulation , 1978, Journal of Biosocial Science.

[36]  A. Oliva,et al.  Determination of Ovarian Function Using First Morning Urine Steroid Assays , 1981, Obstetrics and gynecology.

[37]  W. Collins,et al.  A prospective multicentre study to develop universal immunochemical tests for predicting the fertile period in women , 1985 .

[38]  J. W. Wood,et al.  Urinary estrone conjugate and pregnanediol 3-glucuronide enzyme immunoassays for population research. , 2003, Clinical chemistry.

[39]  A. Kassam,et al.  Identification of anovulation and transient luteal function using a urinary pregnanediol-3-glucuronide ratio algorithm. , 1996, Environmental health perspectives.

[40]  S. Bernstein,et al.  Steroid conjugates. VI. An improved Koenigs-Knorr synthesis of aryl glucuronides using cadmium carbonate, a new and effective catalyst. , 1971, The Journal of organic chemistry.

[41]  J. Overstreet,et al.  Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay. , 1991, Clinical chemistry.

[42]  W. Collins,et al.  The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function. , 1979, Acta endocrinologica.

[43]  C. Weinberg,et al.  Application of a method for estimating day of ovulation using urinary estrogen and progesterone metabolites. , 1995, Epidemiology.

[44]  J. Billings,et al.  Natural family planning , 1978, American journal of obstetrics and gynecology.

[45]  Edward J. Dudewicz,et al.  Modern Mathematical Statistics , 1988 .

[46]  Rebecca C. Miller,et al.  Comparison of specific gravity and creatinine for normalizing urinary reproductive hormone concentrations. , 2004, Clinical chemistry.

[47]  M. Alliende.  Mean versus individual hormonal profiles in the menstrual cycle. , 2002, Fertility and sterility.

[48]  F. Kohen,et al.  Monitoring ovarian function by the simultaneous time-resolved fluorescence immunoassay of two urinary steroid metabolites. , 1998, Clinical chemistry.

[49]  James B. Brown,et al.  Hormonal monitoring of ovarian activity using the Ovarian Monitor, Part I. Validation of home and laboratory results obtained during ovulatory cycles by comparison with radioimmunoassay , 2003, Steroids.

[50]  J. Taieb,et al.  Limitations of steroid determination by direct immunoassay. , 2002, Clinical chemistry.

[51]  J. Brown,et al.  Home monitoring of gonadotropin ovulation induction using the Ovarian Monitor. , 1990, Fertility and Sterility.

[52]  C. Gnoth,et al.  Determination of the fertile window: Reproductive competence of women – European cycle databases , 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[53]  G. B. Bartolucci,et al.  Adjustment to concentration-dilution of spot urine samples: correlation between specific gravity and creatinine , 2000, International archives of occupational and environmental health.

[54]  S. Crawford,et al.  Assessing menstrual cycles with urinary hormone assays. , 2003, American journal of physiology. Endocrinology and metabolism.

[55]  W. Collins,et al.  The measurement of urinary steroid glucuronides as indices of the fertile period in women. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, special programme of research, development and research training in human reproduction. , 1982, Journal of steroid biochemistry.

[56]  A. Curry,et al.  Biochemistry of Women: Clinical Concepts , 1974 .

[57]  L. Blackwell,et al.  Chemical and homogeneous enzyme immunoassay methods for the measurement of estrogens and pregnanediol and their glucuronides in urine. , 1988, Progress in clinical and biological research.

[58]  Juri Rappsilber,et al.  Exploring the hidden human urinary proteome via ligand library beads. , 2005, Journal of proteome research.

[59]  R. C. Miller,et al.  Ovulation detection methods for urinary hormones: precision, daily and intermittent sampling and a combined hierarchical method. , 2006, Human reproduction.

[60]  T. Key,et al.  Interference of sex-hormone binding globulin in a no-extraction double-antibody radioimmunoassay for estradiol. , 1988, Clinical chemistry.

[61]  R F Martin,et al.  General deming regression for estimating systematic bias and its confidence interval in method-comparison studies. , 2000, Clinical chemistry.

[62]  R. Osathanondh,et al.  The production of progesterone, androgens, and estrogens by granulosa cells, thecal tissue, and stromal tissue from human ovaries in vitro. , 1979, The Journal of clinical endocrinology and metabolism.

[63]  Use of the Home Ovarian Monitor in pregnancy avoidance , 1991 .

[64]  E. Odeblad,et al.  Morphological characterization of different human cervical mucus types using light and scanning electron microscopy. , 2003, Human reproduction.

[65]  Royston Jp,et al.  Basal body temperature, ovulation and the risk of conception, with special reference to the lifetimes of sperm and egg. , 1982, Biometrics.

[66]  W. Collins,et al.  An estrogen test to determine the times of potential fertility in women. , 1985, Fertility and Sterility.

[67]  Dietmar Stöckl,et al.  Application of the Bland-Altman plot for interpretation of method-comparison studies: a critical investigation of its practice. , 2002, Clinical chemistry.

[68]  M. Handcock,et al.  Statistical Correction for Non‐parallelism in a Urinary Enzyme Immunoassay , 2004, Journal of immunoassay & immunochemistry.

[69]  R. Bro,et al.  Centering and scaling in component analysis , 2003 .

[70]  T. Baker,et al.  A possible method for the detection of ovulation and the determination of the duration of the fertile period. , 1980, Journal of steroid biochemistry.

[71]  D. Dunson,et al.  Mucus observations in the fertile window: a better predictor of conception than timing of intercourse. , 2004, Human reproduction.